Athira Pharma, Inc. (ATHA) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Athira Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.68 M, a 3.7% decline year-over-year.
Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $10.5 M, a 1.29% decline year-over-year.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6 M, a 0.16% increase from 2022.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6 M, a 129% increase from 2021.
Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.62 M, a 630% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$10.5 M	$2.68 M	-$103 K	-3.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$10.6 M	$2.23 M	-$132 K	-5.59%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$10.8 M	$2.49 M	+$74 K	+3.06%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$10.7 M	$3.12 M	+$24 K	+0.78%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$10.7 M	$2.78 M	+$51 K	+1.87%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	$10.6 M	$2.36 M	+$925 K	+64.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$9.68 M	$2.42 M	+$1.32 M	+119%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$8.37 M	$3.1 M	+$1.99 M	+179%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$6.38 M	$2.73 M	+$1.76 M	+180%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$4.62 M	$1.44 M	+$1.02 M	+246%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$3.6 M	$1.11 M	+$994 K	+895%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$2.61 M	$1.11 M	+$1.06 M	+2163%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	$1.55 M	$974 K	+$916 K	+1579%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$633 K	$415 K			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-28
Q3 2020		$111 K	+$42 K	+60.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$49 K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020		$58 K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q3 2019		$69 K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.